Vignesh G. Ravindranath

University of San Francisco

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Real‐world effectiveness of ustekinumab and vedolizumab in TNF‐exposed pediatric patients with ulcerative colitis”.

Real‐world effectiveness of ustekinumab and vedolizumab in TNF‐exposed pediatric patients with ulcerative colitis

Journal of Pediatric Gastroenterology and Nutrition(2024)10.1002/jpn3.12169

N/A

0.330DataRank · unranked

8 citations

Amy Zhang, Balu Bhasuran, Vignesh G. Ravindranath, Melvin B. Heyman, Sofia G. Verstraete +5 more

Personalizing treatment selection in Crohn’s disease: a meta-analysis of individual participant data from fifteen randomized controlled trials

medRxiv(2023)10.1101/2023.11.10.23291837

N/A

0.104DataRank · unranked

1 citations

Vignesh G. Ravindranath, Douglas V. Arneson, Arman Mosenia, Atul Janardhan Butte, Shan Wang +1 more

From trial data to personalized medicine: a validated framework with an application to Crohn’s disease

npj Digital Medicine(2025)10.1038/s41746-025-01627-w

N/A

0.104DataRank · unranked

1 citations

Vignesh G. Ravindranath, Douglas V. Arneson, Arman Mosenia, Atul Janardhan Butte, Shan Wang +1 more

S936 Optimizing Treatment Selection in Crohn’s Disease Using Patient-Specific Features: An Individual Participant Data Meta-Analysis of Fifteen Randomized Controlled Trials

American Journal of Gastroenterology(2023)10.14309/01.ajg.0000953384.20574.a3

N/A

0DataRank · unranked

0 citations

Douglas V. Arneson, Arman Mosenia, Shan Wang, Vivek Ashok Rudrapatna, Vignesh G. Ravindranath +1 more

Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group

BMC Medical Research Methodology(2023)10.1186/s12874-023-02020-5

N/A

0DataRank · unranked

4 citations

Vignesh G. Ravindranath, Douglas V. Arneson, Arman Mosenia, Atul Janardhan Butte, Shan Wang +1 more

A method for estimating causal effects from heterogeneous clinical trials without a common control group using sequential regression and simulation: an individual participant data meta-analysis and validation study

medRxiv(2022)10.1101/2022.10.07.22280801

N/A

0DataRank · unranked

1 citations

Vignesh G. Ravindranath, Douglas V. Arneson, Arman Mosenia, Atul Janardhan Butte, Shan Wang +1 more

Tu1834 PERSONALIZING TREATMENT SELECTION IN CROHN'S DISEASE: A META-ANALYSIS OF INDIVIDUAL PARTICIPANT DATA FROM FIFTEEN RANDOMIZED CONTROLLED TRIALS

Gastroenterology(2024)10.1016/s0016-5085(24)03735-1

N/A

0DataRank · unranked

0 citations

Vignesh G. Ravindranath, Douglas V. Arneson, Arman Mosenia, Shan Wang, Atul Janardhan Butte +1 more